Literature DB >> 18705618

A review of pediatric uveitis: part II. Autoimmune diseases and treatment modalities.

William P Madigan1, William R Raymond, Keith J Wroblewski, Nuthida Thebpatiphat, Richard H Birdsong, Mohamad S Jaafar.   

Abstract

Uveitis is a manifestation of complex processes that can represent an infectious process or a dysfunction of the immune system that may have grave effects on the eye. Although infectious causes, once properly identified, may be successfully treated by addressing the inciting organism with recognized interventions, the immune-modulated chronic forms of uveitis often provide more complex challenges in management. Recent strides in understanding the inflammatory pathway and better bioengineering capabilities have resulted in some new modalities of treatment.

Entities:  

Mesh:

Year:  2008        PMID: 18705618     DOI: 10.3928/01913913-20080701-10

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  2 in total

1.  Long-term daclizumab therapy for the treatment of noninfectious ocular inflammatory disease.

Authors:  Keith Wroblewski; H Nida Sen; Steven Yeh; Lisa Faia; Zhuging Li; Pushpa Sran; Sapna Gangaputra; Susan Vitale; Patti Sherry; Robert Nussenblatt
Journal:  Can J Ophthalmol       Date:  2011-07-07       Impact factor: 1.882

Review 2.  Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.

Authors:  Merih Oray; İlknur Tuğal-Tutkun
Journal:  Turk J Ophthalmol       Date:  2016-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.